The Senate Finance Committee will hear Tuesday from executives from the biggest pharmacy benefit managers. Confidential rebates paid to the PBMs are expected to draw scrutiny.
(Image credit: Win McNamee/Getty Images)
Drug Industry Middlemen To Be Questioned By Senate Committee
